| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 2025 | Jul 11, 2025 | Denali Therapeutics Inc. | CEO | Sell | 13.8 | -495,282 | -16.78% | ✓ | $7.4M |
| Jan 6, 2025 | Jan 8, 2025 | Denali Therapeutics Inc. | CEO | Sell | 20.0 | -36,916 | -1.48% | ✗ | $751K |
| Oct 18, 2024 | Oct 22, 2024 | Denali Therapeutics Inc. | CEO | Sell | 40.0 | -40,000 | -1.61% | ✓ | $1.1M |
| Aug 20, 2024 | Aug 22, 2024 | Denali Therapeutics Inc. | CEO | Sell | 47.5 | -2,260 | -0.09% | ✗ | $53.8K |
| Feb 13, 2024 | Feb 15, 2024 | Denali Therapeutics Inc. | CEO | Sell | 40.0 | -9,589 | -0.39% | ✗ | $165.8K |
| Jan 9, 2024 | Jan 11, 2024 | Denali Therapeutics Inc. | CEO | Sell | 40.0 | -7,818 | -0.31% | ✗ | $154.6K |
| Jan 5, 2024 | Jan 9, 2024 | Denali Therapeutics Inc. | CEO | Sell | 30.0 | -17,483 | -0.69% | ✗ | $339.7K |
| Aug 21, 2023 | Aug 23, 2023 | Denali Therapeutics Inc. | CEO | Sell | 47.5 | -2,309 | -0.10% | ✗ | $52.2K |
| Aug 10, 2023 | Aug 14, 2023 | Denali Therapeutics Inc. | CEO | Sell | 50.0 | -2,526 | -0.10% | ✓ | $63.2K |
| Jun 16, 2023 | Jun 20, 2023 | Denali Therapeutics Inc. | CEO | Sell | 36.3 | -50,000 | -2.02% | ✓ | $1.6M |
| Apr 20, 2023 | Apr 24, 2023 | Denali Therapeutics Inc. | CEO | Sell | 45.0 | -25,000 | -0.53% | ✓ | $628.7K |
| Feb 13, 2023 | Feb 15, 2023 | Denali Therapeutics Inc. | CEO | Sell | 42.5 | -33,815 | -0.72% | ✓ | $1M |
| Feb 9, 2023 | Feb 13, 2023 | Denali Therapeutics Inc. | CEO | Sell | 45.0 | -28,433 | -0.61% | ✓ | $832.5K |
| Jan 5, 2023 | Jan 9, 2023 | Denali Therapeutics Inc. | CEO | Sell | 47.5 | -4,800 | -0.20% | ✗ | $136.5K |
| Jan 3, 2023 | Jan 5, 2023 | Denali Therapeutics Inc. | CEO | Sell | 87.5 | +77,211 | 3.26% | ✗ | $144.5K |
| Aug 19, 2022 | Aug 23, 2022 | Denali Therapeutics Inc. | CEO | Sell | 47.5 | -2,404 | -0.10% | ✗ | $79.9K |
| Feb 11, 2022 | Feb 15, 2022 | Denali Therapeutics Inc. | CEO | Sell | 37.5 | -9,491 | -0.40% | ✗ | $329.5K |
| Feb 9, 2022 | Feb 11, 2022 | Denali Therapeutics Inc. | CEO | Sell | 47.5 | -2,719 | -0.13% | ✗ | $102.1K |
| Jan 5, 2022 | Jan 7, 2022 | Denali Therapeutics Inc. | CEO | Sell | 40.0 | -5,007 | -0.22% | ✗ | $224.2K |
| Dec 1, 2021 | Dec 3, 2021 | Denali Therapeutics Inc. | CEO | Sell | 45.0 | -18,333 | -0.81% | ✓ | $823.6K |
| Nov 1, 2021 | Nov 3, 2021 | Denali Therapeutics Inc. | CEO | Sell | 45.0 | -18,333 | -0.80% | ✓ | $912.2K |
| Oct 1, 2021 | Oct 5, 2021 | Denali Therapeutics Inc. | CEO | Sell | 45.0 | -18,333 | -0.79% | ✓ | $923.6K |
| Sep 1, 2021 | Sep 3, 2021 | Denali Therapeutics Inc. | CEO | Sell | 42.5 | -18,333 | -0.79% | ✓ | $1M |
| Aug 19, 2021 | Aug 23, 2021 | Denali Therapeutics Inc. | CEO | Sell | 47.5 | -2,376 | -0.10% | ✗ | $117.8K |
| Aug 2, 2021 | Aug 4, 2021 | Denali Therapeutics Inc. | CEO | Sell | 45.0 | -18,333 | -0.78% | ✓ | $942.5K |
| Jul 1, 2021 | Jul 6, 2021 | Denali Therapeutics Inc. | CEO | Sell | 42.5 | -18,333 | -0.77% | ✓ | $1.4M |
| Jun 1, 2021 | Jun 3, 2021 | Denali Therapeutics Inc. | CEO | Sell | 42.5 | -18,333 | -0.77% | ✓ | $1.1M |
| May 3, 2021 | May 5, 2021 | Denali Therapeutics Inc. | CEO | Sell | 42.5 | -18,333 | -0.76% | ✓ | $1.1M |
| Mar 9, 2021 | Apr 5, 2021 | Denali Therapeutics Inc. | CEO | Sell | 36.3 | -58,334 | -2.37% | ✓ | $1M |
| Mar 1, 2021 | Mar 3, 2021 | Denali Therapeutics Inc. | CEO | Sell | 42.5 | -18,334 | -0.74% | ✓ | $1.2M |
| Feb 11, 2021 | Feb 16, 2021 | Denali Therapeutics Inc. | CEO | Sell | 37.5 | -9,473 | -0.38% | ✗ | $666K |
| Feb 8, 2021 | Feb 10, 2021 | Denali Therapeutics Inc. | CEO | Sell | 37.5 | -5,112 | -0.22% | ✗ | $377.2K |
| Feb 1, 2021 | Feb 2, 2021 | Denali Therapeutics Inc. | CEO | Sell | 42.5 | -18,334 | -0.79% | ✓ | $1.3M |
| Jan 4, 2021 | Jan 6, 2021 | Denali Therapeutics Inc. | CEO | Sell | 31.3 | -88,334 | -3.66% | ✓ | $6.6M |
| Mar 30, 2020 | Apr 1, 2020 | Denali Therapeutics Inc. | CEO | Sell | 47.5 | -4,807 | -0.20% | ✗ | $93.6K |
| Dec 3, 2019 | Dec 5, 2019 | Denali Therapeutics Inc. | CEO | Sell | 45.0 | -21,268 | -0.86% | ✓ | $382.9K |
| Nov 22, 2019 | Nov 26, 2019 | Denali Therapeutics Inc. | CEO | Sell | 42.5 | -43,485 | -1.73% | ✓ | $783.6K |
| Sep 3, 2019 | Sep 5, 2019 | Denali Therapeutics Inc. | CEO | Sell | 48.8 | -8,581 | -0.34% | ✓ | $154.9K |
| May 14, 2019 | Jul 3, 2019 | Denali Therapeutics Inc. | CEO | Sell | 38.8 | -58,333 | -2.27% | ✓ | $380.6K |
| Jun 3, 2019 | Jun 5, 2019 | Denali Therapeutics Inc. | CEO | Sell | 45.0 | -18,333 | -0.71% | ✓ | $349.6K |
| May 1, 2019 | May 3, 2019 | Denali Therapeutics Inc. | CEO | Sell | 45.0 | -18,334 | -0.70% | ✓ | $443.7K |
| Apr 1, 2019 | Apr 3, 2019 | Denali Therapeutics Inc. | CEO | Sell | 45.0 | -18,333 | -0.70% | ✓ | $458.8K |
| Mar 1, 2019 | Mar 5, 2019 | Denali Therapeutics Inc. | CEO | Sell | 45.0 | -18,333 | -0.69% | ✓ | $406.6K |
| Feb 1, 2019 | Feb 5, 2019 | Denali Therapeutics Inc. | CEO | Sell | 45.0 | -18,334 | -0.69% | ✓ | $343.3K |
| Jan 2, 2019 | Jan 4, 2019 | Denali Therapeutics Inc. | CEO | Sell | 45.0 | -18,333 | -0.68% | ✓ | $356.3K |
| Nov 27, 2018 | Dec 6, 2018 | Denali Therapeutics Inc. | CEO | Sell | 38.8 | -58,333 | -2.13% | ✓ | $337.9K |
| Nov 13, 2018 | Nov 15, 2018 | Denali Therapeutics Inc. | CEO | Sell | 45.0 | -18,334 | -0.66% | ✓ | $331.7K |
| Oct 1, 2018 | Oct 3, 2018 | Denali Therapeutics Inc. | CEO | Sell | 45.0 | -18,333 | -0.66% | ✓ | $398.2K |
| Sep 4, 2018 | Sep 6, 2018 | Denali Therapeutics Inc. | CEO | Sell | 45.0 | -18,333 | -0.66% | ✓ | $349.4K |
| Aug 29, 2018 | Aug 31, 2018 | Denali Therapeutics Inc. | CEO | Sell | 45.0 | -18,334 | -0.65% | ✓ | $330.9K |